Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burroughs

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Transplantation and Cellular Therapy|September 22, 2024
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular TherapyRaheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersLauri M Burroughs, Akiko Shimamura, Julie-An Talano, et al.
Blood|December 15, 2018
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseasesMonica S Thakar, Larisa Broglie, Brent Logan, et al.
Cell Stem Cell|April 23, 2020
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem CellsNeha Nagpal, Jianing Wang, Jing Zeng, et al.
Pediatric Blood & Cancer|August 11, 2020
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy ConsortiumMichael A Pulsipher, Leslie E Lehmann, Alison A Bertuch, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2016
Hematopoietic stem cell transplantation for CTLA4 deficiencyMary A Slatter, Karin R Engelhardt, Lauri M Burroughs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant CyclophosphamideKanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.
Blood Advances|August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populationsPaul A Carpenter, Ted A Gooley, Julie Boiko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphomaLauri M Burroughs, Paul V O'Donnell, Brenda M Sandmaier, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Transplantation and Cellular Therapy|September 22, 2024
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular TherapyRaheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersLauri M Burroughs, Akiko Shimamura, Julie-An Talano, et al.
Blood|December 15, 2018
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseasesMonica S Thakar, Larisa Broglie, Brent Logan, et al.
Cell Stem Cell|April 23, 2020
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem CellsNeha Nagpal, Jianing Wang, Jing Zeng, et al.
Pediatric Blood & Cancer|August 11, 2020
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy ConsortiumMichael A Pulsipher, Leslie E Lehmann, Alison A Bertuch, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2016
Hematopoietic stem cell transplantation for CTLA4 deficiencyMary A Slatter, Karin R Engelhardt, Lauri M Burroughs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant CyclophosphamideKanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.
Blood Advances|August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populationsPaul A Carpenter, Ted A Gooley, Julie Boiko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphomaLauri M Burroughs, Paul V O'Donnell, Brenda M Sandmaier, et al.
Pageof 9